Welcome to Multibagg AI
Log in to access personalized features
IRIS
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Research powered by GOALZEN CAPITAL SERVICES PRIVATE LIMITED · SEBI Research Analyst INH000013448
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discovery themes featuring this stockBearish
4
Neutral
1
Bullish
9
Bearish
36
Neutral
1
Bullish
9
Bearish
32
Neutral
0
Bullish
0
Bearish
4
Neutral
1
Bullish
9
Bearish
4
Neutral
1
Bullish
9
Bearish
32
Neutral
0
Bullish
0
Bearish
32
Neutral
0
Bullish
0
Bearish
32
Neutral
0
Bullish
0
Thirumalai Chemicals Limited manufactures and sells specialty and commodity chemicals, principally phthalic anhydride, maleic anhydride, malic and fumaric acids, operating manufacturing sites in Ranipet and Dahej (India), a facility in Malaysia, and a large greenfield US facility under construction, servicing paint, UPR, food, pharma and industrial customers across North America, Europe, Middle East and Asia.
The company is commissioning a significant US project: an integrated 40.5 KTPA MAN and 30 KTPA food‑ingredients complex with modular equipment shipped from India, estimated cost near US$340 million and targeted commercial operations in December 2026; management expects payback in about seven years and local market access to improve competitiveness in North America and Europe.
Q1 FY27 showed mixed results: consolidated revenue rose to INR 547 crore (Q1FY26: INR 450 crore) and consolidated EBITDA turned positive at INR 36 crore versus a loss earlier, but consolidated PAT remained negative at INR -44 crore due to sharply higher finance costs and continued project‑related expenditures, while standalone operations delivered improved gross margins and a PAT of INR 14 crore.
TCL emphasizes R&D and quality compliance with a pilot‑scale R&D centre at Ranipet, multiple global certifications (FSSC, REACH, Halal, Kosher), and ZLD plus energy recovery systems; these capabilities support technical differentiation in food and pharma grades and help TCL pursue energy efficiency, traceability and premium specialty applications.
Key near‑term structural dynamics include persistent Chinese oversupply pressuring phthalic anhydride pricing, an extended antidumping duty supporting domestic pricing, feedstock and freight volatility affecting margins, and strategic logistics investments (rail/coastal) intended to reduce costs and improve reach to North and East India customers.
Chemicals & Petrochemicals
Commodity Chemicals
1,449 Cr
High Risk
-9.6
35.0
—
0.9
290.60
117.65
Sales CAGR
Profit CAGR
ROE
ROCE
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Investor Presentation
Q1 FY26
Discovery themes featuring this stock
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
516.50 | 1,563 Cr | 19.14 | 1.17 | 0.99 | 0.17 | 2.94 | 3.55 | ||
117.65 | 1,449 Cr | -9.56 | 0.93 | 0.00 | -10.74 | -2.87 | -3.20 | ||
102.45 | 1,353 Cr | -1828.81 | 0.00 | 0.00 | 9.60 | 103.10 | -7.07 | ||
403.60 | 1,326 Cr | 23.56 | 3.43 | 0.24 | 11.09 | 14.48 | 13.91 | ||
113.90 | 1,224 Cr | 8.82 | 0.94 | 0.88 | 10.17 | 11.74 | 6.52 | ||
77.01 | 1,036 Cr | 9.58 | 0.62 | 1.57 | 6.01 | 8.39 | 5.02 | ||
404.00 | 988 Cr | 38.56 | 6.42 | 0.00 | 13.16 | 12.77 | 5.55 | ||
| Median: 7 Co. | — | 117.65 | 1,326 Cr | 9.58 | 0.94 | 0.24 | 9.60 | 11.74 | 5.02 |
Thirumalai Chemicals Ltd (TIRUMALCHM) is currently trading at 117.65 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Thirumalai Chemicals Limited manufactures and sells specialty and commodity chemicals, principally phthalic anhydride, maleic anhydride, malic and fumaric acids, operating manufacturing sites in Ranipet and Dahej (India), a facility in Malaysia, and a large greenfield US facility under construction, servicing paint, UPR, food, pharma and industrial customers across North America, Europe, Middle East and Asia. The company is commissioning a significant US project: an integrated 40.5 KTPA MAN and 30 KTPA food‑ingredients complex with modular equipment shipped from India, estimated cost near US$340 million and targeted commercial operations in December 2026; management expects payback in about seven years and local market access to improve competitiveness in North America and Europe. Q1 FY27 showed mixed results: consolidated revenue rose to INR 547 crore (Q1FY26: INR 450 crore) and consolidated EBITDA turned positive at INR 36 crore versus a loss earlier, but consolidated PAT remained negative at INR -44 crore due to sharply higher finance costs and continued project‑related expenditures, while standalone operations delivered improved gross margins and a PAT of INR 14 crore. TCL emphasizes R&D and quality compliance with a pilot‑scale R&D centre at Ranipet, multiple global certifications (FSSC, REACH, Halal, Kosher), and ZLD plus energy recovery systems; these capabilities support technical differentiation in food and pharma grades and help TCL pursue energy efficiency, traceability and premium specialty applications. Key near‑term structural dynamics include persistent Chinese oversupply pressuring phthalic anhydride pricing, an extended antidumping duty supporting domestic pricing, feedstock and freight volatility affecting margins, and strategic logistics investments (rail/coastal) intended to reduce costs and improve reach to North and East India customers.
Over the past 52 weeks, Thirumalai Chemicals Ltd has traded between a low of ₹117.65 and a high of ₹290.60. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Thirumalai Chemicals Ltd has a market capitalization of approximately 1,449.04. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Thirumalai Chemicals Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of -9.56 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 1,449.04 Cr, Thirumalai Chemicals Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Thirumalai Chemicals Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Thirumalai Chemicals Ltd is -9.56. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
ICRA downgraded the company’s long-term facilities from BBB+ to BBB with a Negative outlook, and short-term facilities from A2 to A3+.
The results are expected in the July-August 2026 window (indicative) for the quarter ended 30 June 2026.
